Danish company RSP Systems selected Innokas Medical to develop a prototype for a non-invasive glucose monitoring device that has global market potential.

‍

“We chose Innokas Medical because of its long-term experience with the design and manufacturing of medical devices,” says Stefan O. Banke, co-founder and CTO of RSP Systems. “We have found that there is a good understanding of RSP’s needs and a willingness to be flexible when needed. It is a really difficult project to take on and needs a high level of communication between the two parties.”

‍

The partnership with innovative Danish company RSP Systems and the development of RSP’s GlucoBeam® product offers exciting possibilities for the future.